Skip to content

The effect of proprioceptive training on tinnitus, muscle strength and functional capacity in individuals who have sequelae after having had COVID-19: Randomized Clinical Trial

Effect of Proprioceptive Training on Tinnitus, Muscle Strength and Functional Capacity in Individuals with Acute Post-COVID-19 Sequelae: Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7yh559g
Enrollment
Unknown
Registered
2022-07-21
Start date
2022-03-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus, as a cause of diseases classified in other chapters

Interventions

We will have an intervention group, with 10 participants, who will undergo a 12-week proprioceptive training, twice a week lasting 60 minutes
a control group, with 10 participants, who will receive only educational information during this period. Every 6 weeks the intervention group will be reassessed. Proprioceptive training is divided int
2 stage resistance training, with a 20-minute walk
3 stage of strength training, we will use dumbbells and anklet
4 stage of proprioception and balance training
5 stage of relaxation. The intervention group will undergo 4 reassessments during these 12 weeks. At the end of the 4th reassessment, the control group will be called to be reassessed.

Sponsors

Universidade Federal de Pernambuco
Lead Sponsor
Universidade Federal de Pernambuco
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Individuals who have been affected by Covid-19 proven by laboratory examination; Be functionally independent; Absence of severe neurological disease, vascular disorder, labyrinthitis and blindness; Patient without severe foot deformity, requiring therapeutic footwear, and in the spine and who do not have orthopedic deficiencies; Do not use mobility aids; No history of fractures in the lower limbs and spine in recent years.

Exclusion criteria

Exclusion criteria: Individuals with COVID-19; have uncontrolled hypertension, that is, systolic blood pressure at rest (?180 mmHg) and/or diastolic blood pressure at rest (?110 mmHg); uncontrolled arrhythmia; active myocarditis; signs respiratory distress at rest; oxygen saturation less than 88%; acute systemic illness or fever; resting heart rate less than 50 and greater than 100 beats per minute; nausea; dizziness; shortness of breath and/or severe fatigue; drop in 4% of oxygen saturation in relation to the resting value and values ??less than 88%; excessive sweating; anxiety crisis; palpitations; pain or tightness in the chest; presents pain during training; Inadequate execution of activities during the intervention procedure; making it impossible to obtain data; Not signing the consent form

Design outcomes

Primary

MeasureTime frame
Improvement of tinnitus, evaluated by the THI-Tinnitus Handicap Inventory test (this used to evaluate the severity of tinnitus), of dizziness, evaluated by the Berg balance test and by the MiniBesttest, of muscle strength, evaluated by the dynamometer, as well as of functional capacity , evaluated by the 6-minute walk test and the Time-Up-To-Go (TUG). Data collected during the 12 weeks of intervention. No Secondary Outcome Expected.

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactMaria das Graças de Araújo

Universidade Federal de Pernambuco

mgrodriguesaraujo@hotmail.com55(81)2126-8939

Outcome results

None listed

Source: REBEC (via WHO ICTRP)